To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C4orf3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
275 supporting clones for gene C4orf3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AY605045   .a 1 to 599 1 to 599   tiling clone,   599/600
(99 %)
0 diff
(100 %id)
NM_001170330.1   .a 1 to 2959 1 to 2959 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 2959/2959
(100 %)
0 diff
(100 %id)
DA075791 cerebellum .a 256 to 838 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BM721100 eye, fetal eye .a 259 to 1010 1 to 749       749/753
(99 %)
4 diff
(99.5 %id)
DA075786 cerebellum .a 262 to 843 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA264738 caudate nucleus .a 265 to 813 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA386240 thalamus .a 265 to 821 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA421769 cervix .a 265 to 837 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA534759 heart .a 265 to 830 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA876479 Prostate .a 265 to 850 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB250612 uterus .a 265 to 846 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA098080 cerebellum .a 269 to 824 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA468703   .a 269 to 828 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA657952   .a 269 to 822 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA691674   .a 269 to 839 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA824878 pericardium .a 269 to 817 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BI760754 pooled colon, kidney, stomach .a 279 to 994 1 to 716       716/717
(99 %)
1 diff
(99.9 %id)
TI_57147737   .a 279 to 994 69 to 784       716/785
(91 %)
7 diff
(99.2 %id)
FN047157 breast carcinoma .a 280 to 351 72 to 1     Submitted on the opposite strand 72/74
(97 %)
0 diff
(100 %id)
TI_44169491   .a 288 to 965 141 to 818       678/818
(82 %)
6 diff
(99.3 %id)
DA278100 corpus callosum .a 291 to 846 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
TI_45209382   .a 293 to 1092 96 to 901       806/901
(89 %)
22 diff
(97.6 %id)
DB472742 hippocampus .a 294 to 766 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BQ422509 large cell carcinoma, lung .a 297 to 1175 1 to 896       896/913
(98 %)
29 diff
(96.9 %id)
BC017399 Bone marrow, acute myelogenous leukemia .a 299 to 1741 1 to 1442   available from MGC, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 1442/1444
(99 %)
6 diff
(99.6 %id)
DA264173 caudate nucleus .a 300 to 873 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
TI_44345719   .a 300 to 916 85 to 701       617/701
(88 %)
7 diff
(99.1 %id)
DA169543 amygdala .a 302 to 871 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CR590172 Placenta Cot 25-normalized .a 302 to 2298 1 to 1997       1997/1997
(100 %)
0 diff
(100 %id)
TI_45213923   .a 303 to 1048 83 to 831       749/831
(90 %)
18 diff
(97.9 %id)
DA148454 amygdala .a 304 to 872 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
FN112090 breast carcinoma .a 304 to 362 1 to 59       59/63
(93 %)
4 diff
(93.7 %id)
CR616256 Placenta Cot 25-normalized .a 305 to 2299 1 to 1995   tiling clone,   1995/1995
(100 %)
0 diff
(100 %id)
AL515048 neuroblastoma, placenta .a 306 to 1102 1 to 797       797/797
(100 %)
1 diff
(99.9 %id)
AL546292 placenta, Placenta Cot 25-normalized .a 306 to 1256 1 to 947   fully sequenced,   947/947
(100 %)
8 diff
(99.2 %id)
TI_45210271   .a 306 to 888 88 to 670   AAA   583/670
(87 %)
8 diff
(98.9 %id)
CN361058 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 307 to 830 1 to 524   AAA   524/524
(100 %)
0 diff
(100 %id)
DA077978 cerebellum .a 309 to 825 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
CB112465 Liver .a 309 to 854 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DA147055 amygdala .a 310 to 884 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CV574226 cornea, eye .a 310 to 918 1 to 609       609/609
(100 %)
0 diff
(100 %id)
DB177276 kidney, tumor tissue .a 310 to 851 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
H50625 breast .a 313 to 787 1 to 485       485/485
(100 %)
13 diff
(97.4 %id)
CV572914 cornea, eye .a 313 to 892 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AF075061   .a 314 to 887 1 to 574       574/574
(100 %)
0 diff
(100 %id)
TI_44000757   .a 314 to 980 86 to 755       670/755
(88 %)
9 diff
(98.9 %id)
TI_45212786   .a 314 to 1077 83 to 846       764/847
(90 %)
11 diff
(98.8 %id)
DB474542 hippocampus .a 318 to 801 1 to 484       484/484
(100 %)
0 diff
(100 %id)
DB478413 hippocampus .a 318 to 780 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
DB494025 hypothalamus .a 318 to 801 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
DB503121 hypothalamus .a 318 to 789 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
DB504323 hypothalamus .a 318 to 798 1 to 481       481/481
(100 %)
0 diff
(100 %id)
DA017755 adrenal gland .a 319 to 889 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA058032 cerebellum .a 319 to 920 2 to 603   capped   602/602
(100 %)
0 diff
(100 %id)
DA141749 alzheimer cortex .a 319 to 872 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA145148 amygdala .a 319 to 892 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA208851 brain .a 319 to 890 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA275525 corpus callosum .a 319 to 875 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA284289 corpus callosum .a 319 to 875 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA352689 substantia nigra .a 319 to 895 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CN361060 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 319 to 989 1 to 671       671/671
(100 %)
0 diff
(100 %id)
DA584802 lung .a 319 to 898 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CN484095 eye .a 319 to 935 1 to 617       617/617
(100 %)
0 diff
(100 %id)
DA712426   .a 319 to 877 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA753584   .a 319 to 841 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA967508 stomach .a 319 to 883 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB172917 kidney, tumor tissue .a 319 to 892 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB269797 uterus .a 319 to 880 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL543881 placenta, Placenta Cot 25-normalized .a 320 to 1257 20 to 949   fully sequenced,   930/949
(97 %)
36 diff
(96.3 %id)
BQ374736 testis_normal .a 325 to 598 297 to 22       276/313
(88 %)
0 diff
(100 %id)
CN482314 eye .a 325 to 962 1 to 638       638/638
(100 %)
0 diff
(100 %id)
CN361055 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 326 to 888 1 to 563   AAA   563/563
(100 %)
0 diff
(100 %id)
FN109700 breast carcinoma .a 329 to 443 118 to 2     Submitted on the opposite strand 117/118
(99 %)
0 diff
(100 %id)
BQ016407 lung, Metastatic Chondrosarcoma .a 330 to 888 577 to 19   AAA   559/567
(98 %)
0 diff
(100 %id)
DN993672 brain, whole brain .a 330 to 896 8 to 574       567/574
(98 %)
0 diff
(100 %id)
W56713 heart .a 332 to 630 1 to 301   fully sequenced,   301/301
(100 %)
1 diff
(99.7 %id)
CX756178 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 333 to 1046 1 to 705       705/854
(82 %)
11 diff
(98.8 %id)
BX483222   .a 338 to 792 1 to 455       455/455
(100 %)
0 diff
(100 %id)
DA762778 tongue .a 343 to 909 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CX166278 human embryonic stem cells differentiated toan early endodermal cell type .a 350 to 1149 1 to 800       800/800
(100 %)
0 diff
(100 %id)
CX166448 human embryonic stem cells differentiated toan early endodermal cell type .a 352 to 1176 1 to 825       825/825
(100 %)
0 diff
(100 %id)
DB173834 kidney, tumor tissue .a 353 to 917 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA616983   .a 356 to 933 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
TI_59388839   .a 357 to 888 107 to 639   AAA   533/533
(100 %)
3 diff
(99.5 %id)
AK025703   .a 358 to 2326 1 to 1970   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 1970/1970
(100 %)
5 diff
(99.8 %id)
AW389679 stomach .a 360 to 845 510 to 21       490/511
(95 %)
6 diff
(98.9 %id)
DA706108   .a 360 to 905 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
TI_149285114   .a 362 to 888 619 to 94   AAA   526/1067
(49 %)
4 diff
(99.7 %id)
AA298595 lung .a 363 to 645 1 to 283       283/283
(100 %)
0 diff
(100 %id)
F12280 brain, total brain .a 363 to 693 1 to 331       331/331
(100 %)
0 diff
(100 %id)
FN110785 breast carcinoma .a 364 to 448 97 to 6     Submitted on the opposite strand 92/98
(93 %)
0 diff
(100 %id)
FN138548 breast carcinoma .a 364 to 473 109 to 1     Submitted on the opposite strand 109/109
(100 %)
1 diff
(99.1 %id)
AA297212   .a 365 to 644 1 to 280       280/280
(100 %)
0 diff
(100 %id)
DA013835 adrenal gland .a 368 to 944 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BQ332401 lung_tumor .a 370 to 542 220 to 49       172/220
(78 %)
0 diff
(100 %id)
BM789026 Ascites, stomach .a 372 to 888 1 to 517   AAA   517/517
(100 %)
0 diff
(100 %id)
TI_154194880   .a 372 to 888 41 to 557   AAA   517/517
(100 %)
3 diff
(99.5 %id)
TI_154192796   .a 373 to 888 50 to 565   AAA   516/516
(100 %)
0 diff
(100 %id)
BX442075 brain, fetal brain .a 374 to 1337 1 to 954       954/954
(100 %)
10 diff
(99.0 %id)
CF130775 Chondrosarcoma Lung Metastasis cell lines, lung .a 374 to 888 1 to 515   AAA   515/515
(100 %)
0 diff
(100 %id)
CB151396 cervix, Uterine .a 375 to 886 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BJ995859 hepatoblastoma .a 378 to 855 1 to 478       478/478
(100 %)
0 diff
(100 %id)
TI_45209319   .a 378 to 1079 88 to 787       700/787
(88 %)
13 diff
(98.4 %id)
TI_44344796   .a 378 to 921 89 to 640       552/990
(55 %)
21 diff
(97.9 %id)
DA659008   .a 379 to 928 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA939161 Spleen .a 379 to 983 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DB128834 thymus .a 379 to 924 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA371679 thalamus .a 382 to 937 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BX345719 Placenta Cot 25-normalized .a 382 to 1303 1 to 915       915/961
(95 %)
16 diff
(98.4 %id)
ES309024 occipital hair of pubic hypotrichosispatient, skin .a 382 to 876 1 to 493       493/504
(97 %)
3 diff
(99.5 %id)
DA672221   .a 382 to 959 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA877503 Prostate .a 382 to 952 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
TI_149282904   .a 382 to 888 586 to 80   AAA   507/822
(61 %)
1 diff
(99.9 %id)
CD105219 brain, Pituitary .a 383 to 888 1 to 506   AAA   506/506
(100 %)
0 diff
(100 %id)
FE192871   .a 389 to 838 123 to 574       452/574
(78 %)
9 diff
(98.5 %id)
CX873565 embryonic stem .a 390 to 1190 1 to 801       801/801
(100 %)
0 diff
(100 %id)
AL547574 placenta, Placenta Cot 25-normalized .a 391 to 1283 1 to 880   fully sequenced,   880/880
(100 %)
5 diff
(99.5 %id)
CR605135 Placenta Cot 25-normalized .a 392 to 2291 1 to 1900       1900/1900
(100 %)
0 diff
(100 %id)
BM688485 eye, eye anterior segment .a 392 to 860 9 to 477       469/477
(98 %)
0 diff
(100 %id)
CR993219 T-Lymphocytes .a 394 to 1265 1 to 870       870/871
(99 %)
2 diff
(99.8 %id)
BM710099 eye, optic nerve .a 394 to 888 1 to 495   fully sequenced, AAA   495/495
(100 %)
1 diff
(99.8 %id)
AW068296 Bone, Hip .a 395 to 793 8 to 406       399/406
(98 %)
0 diff
(100 %id)
CR597270 Placenta Cot 25-normalized .a 396 to 2289 1 to 1894       1894/1894
(100 %)
0 diff
(100 %id)
AL548220 placenta, Placenta Cot 25-normalized .a 396 to 1412 1 to 1011       1011/1028
(98 %)
11 diff
(99.0 %id)
N44239 melanocyte .a 397 to 630 1 to 235   fully sequenced,   235/235
(100 %)
0 diff
(100 %id)
CV574358 cornea, eye .a 401 to 888 1 to 488   AAA   488/488
(100 %)
0 diff
(100 %id)
DT215301 brain .a 407 to 967 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BY994397   .a 412 to 888 512 to 37   AAA Submitted on the opposite strand 476/634
(75 %)
5 diff
(99.3 %id)
AI814550 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 416 to 888 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AW007378 anaplastic oligodendroglioma, brain .a 417 to 889 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AI183430 placenta .a 422 to 890 469 to 1       469/469
(100 %)
0 diff
(100 %id)
BG058554 blood, lymphocyte .a 427 to 887 461 to 1       461/461
(100 %)
0 diff
(100 %id)
EL951649 eyeball .a 433 to 886 24 to 478       455/478
(95 %)
9 diff
(98.2 %id)
AI658542 Prostate .a 434 to 888 455 to 1       455/455
(100 %)
0 diff
(100 %id)
BE550056 carcinoid, lung .a 434 to 888 467 to 13   AAA   455/455
(100 %)
0 diff
(100 %id)
H68452 liver and spleen .a 437 to 637 1 to 201   fully sequenced,   201/201
(100 %)
0 diff
(100 %id)
AA134140 uterus .a 440 to 891 452 to 1       452/452
(100 %)
0 diff
(100 %id)
H50626 breast .a 441 to 888 456 to 1       456/464
(98 %)
12 diff
(97.5 %id)
CX785220 human embryonic stem cells .a 453 to 960 1 to 508       508/508
(100 %)
0 diff
(100 %id)
GW493271 diffuse (Lauren) gastric adenocarcinoma, stomach .a 457 to 830 394 to 21   AAA Submitted on the opposite strand 374/374
(100 %)
1 diff
(99.8 %id)
AW847015 colon .a 464 to 691 240 to 13       228/240
(95 %)
0 diff
(100 %id)
AW768701 lymph node, lymphoma, follicular mixed small and largecell .a 474 to 891 418 to 1       418/418
(100 %)
0 diff
(100 %id)
DA663786   .a 478 to 1045 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AI343798 2 pooled tumors (clear cell type), Kidney .a 486 to 891 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI031910 parathyroid gland, parathyroid tumor .a 494 to 888 412 to 18   AAA   395/395
(100 %)
0 diff
(100 %id)
AI214566 carcinoid, lung .a 494 to 888 406 to 12   AAA   395/395
(100 %)
0 diff
(100 %id)
AW268669 lung, two pooled squamous cell carcinomas .a 495 to 890 396 to 1       396/396
(100 %)
0 diff
(100 %id)
F32126 pectoral muscle (after mastectomy) .a 495 to 682 1 to 188       188/188
(100 %)
0 diff
(100 %id)
AI219039 placenta .a 505 to 887 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AA298889 thyroid gland .a 520 to 757 1 to 238       238/238
(100 %)
0 diff
(100 %id)
W69875 heart .a 527 to 891 1 to 365   fully sequenced,   365/365
(100 %)
1 diff
(99.8 %id)
AI300284 placenta .a 532 to 891 360 to 1       360/360
(100 %)
0 diff
(100 %id)
CV330279 uterus_tumor .a 556 to 847 295 to 4     Submitted on the opposite strand 292/298
(97 %)
1 diff
(99.7 %id)
DA134028 alzheimer cortex .a 559 to 1127 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
FN060921 breast carcinoma .a 562 to 641 81 to 1     Submitted on the opposite strand 81/82
(98 %)
1 diff
(98.8 %id)
W69768 heart .a 565 to 877 313 to 1   fully sequenced,   313/313
(100 %)
1 diff
(99.7 %id)
N35996 melanocyte .a 569 to 888 322 to 1   fully sequenced,   322/322
(100 %)
3 diff
(99.1 %id)
AA694466 parathyroid gland, parathyroid tumor .a 571 to 888 318 to 1       318/318
(100 %)
0 diff
(100 %id)
FN050448 breast carcinoma .a 583 to 689 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AW518176 lymph node, lymphoma, follicular mixed small and largecell .a 588 to 888 1 to 301     Submitted on the opposite strand 301/301
(100 %)
0 diff
(100 %id)
FN099136 breast carcinoma .a 591 to 694 106 to 1     Submitted on the opposite strand 106/109
(97 %)
4 diff
(96.4 %id)
W56758 heart .a 591 to 889 300 to 1   fully sequenced,   300/300
(100 %)
6 diff
(98.0 %id)
DR979382 placenta .a 594 to 888 1 to 290   AAA Submitted on the opposite strand 290/292
(99 %)
7 diff
(97.7 %id)
DR979387 placenta .a 594 to 830 1 to 232   AAA Submitted on the opposite strand 232/234
(99 %)
6 diff
(97.5 %id)
AW241640 Kidney .a 594 to 852 9 to 267     Submitted on the opposite strand 259/259
(100 %)
0 diff
(100 %id)
AI289413 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 599 to 889 291 to 1       291/291
(100 %)
0 diff
(100 %id)
H68775 liver and spleen .a 607 to 897 292 to 2   fully sequenced,   291/292
(99 %)
4 diff
(98.7 %id)
FN144508 breast carcinoma .a 612 to 717 116 to 4     Submitted on the opposite strand 113/118
(95 %)
0 diff
(100 %id)
FN049303 breast carcinoma .a 640 to 755 116 to 1     Submitted on the opposite strand 116/116
(100 %)
0 diff
(100 %id)
FN064128 breast carcinoma .a 649 to 723 1 to 76       76/77
(98 %)
4 diff
(94.9 %id)
AI589200 Kidney .a 649 to 890 242 to 1       242/242
(100 %)
0 diff
(100 %id)
FN060023 breast carcinoma .a 654 to 733 1 to 75       75/76
(98 %)
8 diff
(89.5 %id)
AA362531   .a 700 to 883 184 to 1     Submitted on the opposite strand 184/184
(100 %)
0 diff
(100 %id)
FN103633 breast carcinoma .a 712 to 800 85 to 1     Submitted on the opposite strand 85/86
(98 %)
5 diff
(94.2 %id)
AA747014 alveolar rhabdomyosarcoma .a 725 to 887 163 to 1       163/163
(100 %)
0 diff
(100 %id)
BM671264 eye, optic nerve .a 729 to 888 178 to 19   fully sequenced, AAA   160/160
(100 %)
0 diff
(100 %id)
AI510711 aorta .a 830 to 891 62 to 1       62/62
(100 %)
0 diff
(100 %id)
FN149914 breast carcinoma .a 871 to 976 108 to 3     Submitted on the opposite strand 106/112
(94 %)
0 diff
(100 %id)
AL570189 placenta, Placenta Cot 25-normalized .a 1227 to 2298 1065 to 1   fully sequenced,   1065/1065
(100 %)
29 diff
(97.3 %id)
AL571684 placenta, Placenta Cot 25-normalized .a 1234 to 2296 1061 to 4   fully sequenced,   1058/1061
(99 %)
0 diff
(100 %id)
AL547543 placenta, Placenta Cot 25-normalized .a 1253 to 2291 1033 to 1   fully sequenced,   1033/1033
(100 %)
56 diff
(94.6 %id)
BX345718 Placenta Cot 25-normalized .a 1324 to 2313 989 to 1       989/1014
(97 %)
33 diff
(96.8 %id)
BX413526 brain, fetal brain .a 1443 to 2271 885 to 44       842/888
(94 %)
0 diff
(100 %id)
BM679526 eye, fetal eye .a 1753 to 2327 592 to 18       575/592
(97 %)
0 diff
(100 %id)
F09905 brain, total brain .a 1996 to 2326 331 to 1       331/331
(100 %)
0 diff
(100 %id)
BM422337 testis .b 1 to 289 1 to 289   tiling clone,   289/289
(100 %)
2 diff
(99.4 %id)
BX499102 Liver .b 180 to 837 1 to 659 F17S F23X I27X tiling clone,   659/659
(100 %)
3 diff
(99.6 %id)
NM_001001701.3   .b 289 to 3126 1 to 2838 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 2838/2838
(100 %)
0 diff
(100 %id)
DA353224 substantia nigra .b 290 to 846 2 to 558 exact tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
TI_154100348   .c-u 1 to 706 43 to 748   tiling clone, Submitted on the opposite strand 706/752
(93 %)
7 diff
(99.1 %id)
TI_159696526   .c-u 313 to 1166 930 to 84   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 847/991
(85 %)
19 diff
(98.1 %id)
BU508234 leiomyosarcoma, uterus .c-u 328 to 1043 1 to 731       731/1031
(70 %)
16 diff
(98.5 %id)
AK024537 adipose tissue .c-u 340 to 1157 1 to 818   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 818/818
(100 %)
1 diff
(99.9 %id)
FN060685 breast carcinoma .c-u 351 to 467 1 to 117       117/117
(100 %)
1 diff
(99.2 %id)
BM700188 eye, lens .c-u 408 to 1067 1 to 660       660/660
(100 %)
0 diff
(100 %id)
FN132768 breast carcinoma .c-u 498 to 586 89 to 1     Submitted on the opposite strand 89/90
(98 %)
2 diff
(97.8 %id)
BF925375 nervous_tumor .c-u 638 to 1131 494 to 1     Submitted on the opposite strand 494/499
(98 %)
17 diff
(96.6 %id)
BF925383 nervous_tumor .c-u 639 to 1131 493 to 1     Submitted on the opposite strand 493/493
(100 %)
12 diff
(97.6 %id)
TI_57188061   .c-u 693 to 1157 50 to 513   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 464/464
(100 %)
2 diff
(99.6 %id)
BM770017 stomach .c-u 700 to 1328 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BQ083895 stomach .c-u 700 to 1083 1 to 384       384/384
(100 %)
0 diff
(100 %id)
BQ084457 stomach .c-u 700 to 1064 1 to 365       365/365
(100 %)
0 diff
(100 %id)
AI493231 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c-u 707 to 1170 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AI453402 adenocarcinoma, Pancreas .c-u 707 to 1157 464 to 14   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 451/451
(100 %)
0 diff
(100 %id)
CA442721 lung, Lung Focal Fibrosis .c-u 708 to 1328 1 to 620     Submitted on the opposite strand 620/620
(100 %)
4 diff
(99.4 %id)
BE677428 dorsal root ganglia .c-u 757 to 1170 414 to 1       414/414
(100 %)
0 diff
(100 %id)
DT220130 brain .c-u 788 to 1448 1 to 661       661/661
(100 %)
0 diff
(100 %id)
CR610189 placenta .c-u 822 to 1741 1 to 920   tiling clone,   920/920
(100 %)
0 diff
(100 %id)
TI_149303300   .c-u 859 to 1740 942 to 79   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 864/939
(92 %)
21 diff
(97.8 %id)
AI925084 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c-u 861 to 1157 297 to 1       297/297
(100 %)
0 diff
(100 %id)
W94211 heart .c-u 917 to 1160 1 to 244       244/244
(100 %)
0 diff
(100 %id)
DB504321 hypothalamus .c-u 936 to 1423 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BM981335 lung, Primary Lung Cystic Fibrosis EpithelialCells .c-u 953 to 1740 800 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 784/786
(99 %)
5 diff
(99.4 %id)
FN133482 breast carcinoma .c-u 959 to 1060 99 to 1     Submitted on the opposite strand 99/99
(100 %)
3 diff
(97.0 %id)
TI_149303417   .c-u 974 to 1740 838 to 80   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 759/941
(80 %)
9 diff
(99.1 %id)
TI_154051511   .c-u 976 to 1740 838 to 79   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 760/953
(79 %)
30 diff
(96.9 %id)
EC499669 Prostate .c-u 980 to 1077 99 to 1       99/102
(97 %)
1 diff
(99.1 %id)
BI038913 nervous_tumor .c-u 992 to 1261 272 to 1       272/272
(100 %)
2 diff
(99.3 %id)
BI039316 nervous_tumor .c-u 993 to 1261 269 to 1       269/269
(100 %)
0 diff
(100 %id)
BQ573963 Chondrosarcoma Grade II, Left Pelvis .c-u 1011 to 1739 746 to 18       729/746
(97 %)
0 diff
(100 %id)
TI_149283157   .c-u 1012 to 1740 801 to 80   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 722/800
(90 %)
13 diff
(98.4 %id)
BM981438 lung, Primary Lung Cystic Fibrosis EpithelialCells .c-u 1084 to 1740 673 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 657/657
(100 %)
0 diff
(100 %id)
BU630724 cell lines, Chondrosarcoma .c-u 1085 to 1738 672 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
BM999836 Fibrosarcoma .c-u 1088 to 1740 669 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 653/653
(100 %)
0 diff
(100 %id)
BU680064 lung, Primary Lung Epithelial Cells .c-u 1104 to 1740 652 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 636/636
(100 %)
1 diff
(99.9 %id)
CA429178 Cell Line, Chondrosarcoma .c-u 1146 to 1740 611 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 595/595
(100 %)
0 diff
(100 %id)
TI_154019176   .c-u 1148 to 1741 681 to 109       573/696
(82 %)
0 diff
(100 %id)
BM505307 Pancreas, Purified pancreatic islet .c-u 1177 to 1739 563 to 1       563/563
(100 %)
0 diff
(100 %id)
CA435899 lung, Metastatic Chondrosarcoma .c-u 1177 to 1740 580 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 564/564
(100 %)
0 diff
(100 %id)
TI_151739751   .c-u 1178 to 1740 684 to 110   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 575/1007
(57 %)
14 diff
(98.7 %id)
AA134262 colon, tumor .c-u 1209 to 1474 1 to 267   fully sequenced,   267/267
(100 %)
1 diff
(99.7 %id)
TI_151738105   .c-u 1233 to 1741 617 to 108       510/1096
(46 %)
0 diff
(100 %id)
TI_151739791   .c-u 1234 to 1740 616 to 108   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 509/1012
(50 %)
12 diff
(98.9 %id)
W63791 heart .c-u 1244 to 1740 496 to 1       496/504
(98 %)
1 diff
(99.9 %id)
DB575563 hypothalamus .c-u 1245 to 1738 1 to 494     Submitted on the opposite strand 494/494
(100 %)
2 diff
(99.6 %id)
DB575565 hypothalamus .c-u 1250 to 1740 1 to 491     Submitted on the opposite strand 491/491
(100 %)
1 diff
(99.8 %id)
BQ364631 stomach_normal .c-u 1251 to 1445 212 to 16       197/213
(92 %)
0 diff
(100 %id)
TI_149279404   .c-u 1263 to 1738 557 to 82   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 476/694
(68 %)
0 diff
(100 %id)
BM023339 Islets of Langerhans, Pancreas .c-u 1266 to 1746 1 to 481   fully sequenced, Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 481/481
(100 %)
1 diff
(99.8 %id)
TI_59391790   .c-u 1275 to 1738 53 to 515   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 463/463
(100 %)
1 diff
(99.8 %id)
AW377604 colon .c-u 1278 to 1697 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AW851846 colon .c-u 1278 to 1703 429 to 5       425/429
(99 %)
0 diff
(100 %id)
AW852050 colon .c-u 1278 to 1703 437 to 12       426/437
(97 %)
0 diff
(100 %id)
DB574331 hypothalamus .c-u 1284 to 1740 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
DB541488 hippocampus .c-u 1289 to 1742 1 to 454     Submitted on the opposite strand 454/454
(100 %)
2 diff
(99.6 %id)
DB565060 hypothalamus .c-u 1289 to 1740 1 to 452     Submitted on the opposite strand 452/452
(100 %)
0 diff
(100 %id)
AI823486 Kidney .c-u 1293 to 1740 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI708199 colon .c-u 1294 to 1736 443 to 1       443/443
(100 %)
0 diff
(100 %id)
DB543360 hippocampus .c-u 1296 to 1767 1 to 472     Submitted on the opposite strand 472/474
(99 %)
1 diff
(99.8 %id)
BM716040 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 1300 to 1784 1 to 485   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
BF003056 Prostate .c-u 1308 to 1740 443 to 11   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
AI261842 Kidney .c-u 1314 to 1741 428 to 1       428/428
(100 %)
0 diff
(100 %id)
AI309606 2 pooled tumors (clear cell type), Kidney .c-u 1314 to 1738 436 to 12   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
DB547063 hippocampus .c-u 1315 to 1740 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
AW852179 colon .c-u 1321 to 1697 376 to 1       376/376
(100 %)
2 diff
(99.5 %id)
AI472005 pooled .c-u 1332 to 1738 420 to 14   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
AW840169 leiomios .c-u 1333 to 1695 1 to 367       367/367
(100 %)
21 diff
(94.3 %id)
CK822588 Pancreas, Purified pancreatic islet .c-u 1341 to 1740 413 to 14   AAA Submitted on the opposite strand 400/400
(100 %)
2 diff
(99.5 %id)
AW885135 ovary .c-u 1343 to 1530 193 to 6       188/193
(97 %)
0 diff
(100 %id)
AW885138 ovary .c-u 1343 to 1538 198 to 4       195/198
(98 %)
13 diff
(93.5 %id)
BE833454 ovary .c-u 1343 to 1528 196 to 11       186/196
(94 %)
0 diff
(100 %id)
BE833513 ovary .c-u 1343 to 1531 192 to 8       185/192
(96 %)
0 diff
(100 %id)
BE833528 ovary .c-u 1343 to 1528 349 to 164       186/202
(92 %)
0 diff
(100 %id)
C75174   .c-u 1345 to 1738 408 to 11   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 398/398
(100 %)
5 diff
(98.8 %id)
FN082360 breast carcinoma .c-u 1346 to 1427 1 to 82       82/82
(100 %)
0 diff
(100 %id)
BE833565 ovary .c-u 1348 to 1538 191 to 1       191/195
(97 %)
0 diff
(100 %id)
AA976693 carcinoid, lung .c-u 1354 to 1738 385 to 1       385/385
(100 %)
0 diff
(100 %id)
BE833435 ovary .c-u 1360 to 1528 179 to 11       169/179
(94 %)
0 diff
(100 %id)
BE833628 ovary .c-u 1360 to 1538 200 to 24       177/200
(88 %)
0 diff
(100 %id)
AI474799 Kidney .c-u 1377 to 1738 362 to 1       362/362
(100 %)
0 diff
(100 %id)
BE139625 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c-u 1388 to 1738 362 to 12   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
BE673718 carcinoid, lung .c-u 1403 to 1726 1 to 324     Submitted on the opposite strand 324/324
(100 %)
0 diff
(100 %id)
AI216102 carcinoid, lung .c-u 1405 to 1727 1 to 323     Submitted on the opposite strand 323/323
(100 %)
0 diff
(100 %id)
BU608493 Human Lung Epithelial cells, lung .c-u 1428 to 1703 8 to 283     Submitted on the opposite strand 276/292
(94 %)
8 diff
(97.3 %id)
AA988545 carcinoid, lung .c-u 1441 to 1738 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AA910038 pooled .c-u 1442 to 1738 316 to 20   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 297/297
(100 %)
0 diff
(100 %id)
AA134263 colon, tumor .c-u 1450 to 1739 290 to 1   fully sequenced,   290/290
(100 %)
0 diff
(100 %id)
CA437919 lung, Metastatic Chondrosarcoma .c-u 1458 to 1741 301 to 18       284/301
(94 %)
0 diff
(100 %id)
AA809548 normal prostatic epithelial cells, Prostate .c-u 1515 to 1738 247 to 24   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 224/224
(100 %)
0 diff
(100 %id)
BM023089 Islets of Langerhans, Pancreas .c-u 1526 to 1745 233 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
BE221821 Kidney .c-u 1549 to 1740 192 to 1       192/192
(100 %)
0 diff
(100 %id)
BU739784 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 1754 to 2373 636 to 17 exact tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
DB031629 testis .d-u 1 to 461 6 to 466 exact capped   465/465
(100 %)
0 diff
(100 %id)
DB162542 thymus .d-u 1 to 476 6 to 481 exact capped   480/480
(100 %)
0 diff
(100 %id)
DB112786 thymus .d-u 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BX497388 Liver .d-u 34 to 603 1 to 569 S18P R66K     569/570
(99 %)
10 diff
(98.3 %id)
DB102893 thymus .d-u 41 to 589 2 to 550 exact capped   549/549
(100 %)
0 diff
(100 %id)
DB176170 kidney, tumor tissue .d-u 99 to 680 2 to 585 G2A G9W W10L T11D S12L ... tiling clone, capped   584/584
(100 %)
3 diff
(99.5 %id)
DB122215 thymus .d-u 111 to 662 2 to 553 exact capped   552/552
(100 %)
2 diff
(99.7 %id)
DB124756 thymus .d-u 111 to 508 2 to 399 S69X capped   398/398
(100 %)
0 diff
(100 %id)
BQ332547 lung_tumor .d-u 120 to 615 7 to 503 C29A H30M G31V E32S Y33I ...     497/503
(98 %)
6 diff
(98.9 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes